EU - EFSA evaluates safety of Ractopamine in feed
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902437175.htm
08-Apr-2009 (17 years 1 months 30 days ago)EFSA’s FEEDAP Panel has just published an opinion on the safety of ractopamine, a growth promoter used in animal feed in some countries outside the EU.
EFSA’s FEEDAP Panel found weaknesses in the data underlying the JECFA assessment which would undermine any proposal for a maximum residue level for ractopamine. The Panel found that the study on cardiovascular effects in humans cannot be taken as a basis to derive an Acceptable Daily Intake (ADI) of 0-1 micrograms per kilogramme of body weight per day as proposed by JECFA. EFSA consulted the Community Reference Laboratory responsible for beta-agonists and the European Medicines Agency (EMEA) and included the results of this process in its final opinion.
EFSA’s FEEDAP Panel found weaknesses in the data underlying the JECFA assessment which would undermine any proposal for a maximum residue level for ractopamine. The Panel found that the study on cardiovascular effects in humans cannot be taken as a basis to derive an Acceptable Daily Intake (ADI) of 0-1 micrograms per kilogramme of body weight per day as proposed by JECFA. EFSA consulted the Community Reference Laboratory responsible for beta-agonists and the European Medicines Agency (EMEA) and included the results of this process in its final opinion.